drugset / Trial / NCT02932007

Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

NCT02932007

Phase 2 Recruiting 40 enrolled University of South Florida
NaSingle-groupOpen-labelTreatment

Summary

The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.

Timeline

Start
2017-03-28
Primary completion
2020-03
Completion
2020-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule 500 mg Oral

Indications